SEC FORM 4
$160,796.93
UNITED THERAPEUTICS Corp (UTHR)
Sale of 321 shares at $500.925 per share.
Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S
Traded Aug 14, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001106578-26-000121 · filed 2026-08-17 · View filing →